JIRI DAVID SONEK, MD
Medical Practice in Dayton, OH

License number
Ohio 35049770
Category
Medical Practice
Type
Maternal & Fetal Medicine
Address
Address
1 Wyoming St Berry Bldg FL GROUND, Dayton, OH 45409
Phone
(937) 208-2516
(937) 208-6124 (Fax)

Professional information

Jiri Sonek Photo 1

Needle Guide Systems And Methods

US Patent:
7022082, Apr 4, 2006
Filed:
May 13, 2002
Appl. No.:
10/144372
Inventors:
Jiri D. Sonek - Beavercreek OH, US
International Classification:
A61B 19/00
US Classification:
600461, 606130, 600417
Abstract:
A needle guide system comprises a base adapted for non-pivotal connection to an imaging device, an arm pivotally connected to the base, and a needle guide pivotally connected to the arm at a point distal from the arm-base connection. The needle guide is adapted to receive at least one needle. The length of the arm extending between the base and the needle guide is adjustable. Methods for positioning a needle relative to an imaging device employ the needle guide system.


Jiri D Sonek Photo 2

Dr. Jiri D Sonek - MD (Doctor of Medicine)

Hospitals:
Perinatal Partners LLC
1 Wyoming St, Dayton 45409
Perinatal Partners LLC
2350 Miami Valley Dr, Centerville 45459
Perinatal Partners LLC
900 S Dixie Dr, Vandalia 45377
Miami Valley Hospital
1 Wyoming St, Dayton 45409
Perinatal Partners LLC
1 Wyoming St, Dayton 45409
Perinatal Partners LLC
2350 Miami Valley Dr, Centerville 45459
Perinatal Partners LLC
900 S Dixie Dr, Vandalia 45377
Miami Valley Hospital
1 Wyoming St, Dayton 45409
Education:
Medical Schools
Pritzker School Of Medicine/University Of Chicago
Graduated: 1981


Jiri Sonek Photo 3

Methods Of Prenatal Screening For Trisomy 21

US Patent:
7922660, Apr 12, 2011
Filed:
Aug 1, 2007
Appl. No.:
11/888554
Inventors:
Jiri D. Sonek - Beavercreek OH, US
Kypros H. Nicolaides - London, GB
International Classification:
A61B 8/00
US Classification:
600437, 382128
Abstract:
Methods for prenatal screening for trisomy 21 employ examination of the fronto-maxillary facial (FMF) angle of a fetus. The methods may comprise obtaining a two or three dimensional image of a fetal face, measuring the FMFangle and/or FMFangle on the image, and comparing the measured FMFangle and/or FMFangle with an FMFangle and/or FMFangle characteristic of chromosomally normal fetuses. A measured FMFangle and/or FMFangle greater than the FMFangle and/or FMFangle characteristic of chromosomally normal fetuses provides an indication of an increased likelihood of the occurrence of trisomy 21 in the fetus.